Dear Clare (
@Action for M.E. ),
Thank you for engaging on this.
My original comment was made to agree with another that AfME has supported behavioural therapies in terms of trials, in the past at least, and that it has been hard to discern a shift of position. I was recently disappointed when AfME withdrew from involvement in the UK ME Biobank to focus on MEGA when at the time many figures involved in MEGA were vociferously supporting behavioural therapies in public. There is an ongoing hope that things will change, and there have been signs that they might, but people find it hard to read AfME's position.
The information pages on treatments look as if they have been recently updated and do look quite 'balanced'. My problem is that, as someone who got drawn in to the ME debate by chance, having been asked to advise on research quality, I think this 'balance' misses out some simple issues that would help patients see things more clearly.
The NICE account of CBT is deliberately misleading (on their part). CBT for ME is based on the 'BPS' idea that perpetuation of ME is due to illness beliefs and that patients have a 'choice' whether to be ill or not (Wade and Halligan BMJ 2004). The objective of ME CBT is to persuade the patient, using 'cognitive strategies', that they will be better if they get into a frame of mind of getting better. And it is the 'responsibility' of the patient to agree to being persuaded (all in Wessely, David, Butler, and Chalder 1989). And nobody actually knows if this story of illness belief is right! Shouldn't patients be aware of what the treatment really is?
In the context of open label studies the result of this coercive persuasion is that patients end up reporting that they feel they are getting better - it is self-fulfilling. Physiotherapists used to do trials like this in rheumatology thirty years ago and we realised that the results were just due to the patients saying what they were told to say. PACE would never have been published in a genuinely peer reviewed journal like the Annals of Rheumatic Diseases or Arthritis and Rheumatism. I find it bizarre that people are still claiming that you can draw any conclusions from the CBT and GET trials in ME. But I should not be surprised because muddled thinking is so widespread amongst doctors.
If AfME is a government mouthpiece then I can understand the sense that government based information, as from NICE, should be placed first. But if AfME is an independent advice service for patients that seems to me naïve. NICE has always had heavy political overlay, with evidence for expensive treatments like biological drugs produced by industry downplayed and evidence for cheap treatments provided by the NHS itself overrated.
I am not seeking to set up a debate here because it is only fair to let people at AfME follow their own judgments, and I respect that. But I do share with the patients the desire to see from AfME a clearer sign that allegiances are changing, if indeed they are. The patients have sorted out the science here very well. It boils down to common sense in the end and it would be good to know that at least everyone supporting PWME is aware of the arguments.